Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: CalciMedica Inc., 3 years.
CalciMedica Inc.
Director
Surrozen Inc.
Director
Cerus Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 11, 2024 | Mirum Pharmaceuticals Inc. | Option exercise | +18,334 | — | — |
| Jun 5, 2024 | Cerus Corporation | Grant or award | +40,000 | $5.00 | $200,000 |
| May 10, 2024 | Mirum Pharmaceuticals Inc. | Grant or award | +470 | $21.05 | $9,894 |
| Mar 27, 2024 | Mirum Pharmaceuticals Inc. | Open-market purchase | +2,000 | $24.80 | $49,600 |
| Mar 18, 2024 | Mirum Pharmaceuticals Inc. | Open-market purchase | +2,000 | $25.80 | $51,600 |
| Dec 13, 2023 | Cerus Corporation | Open-market purchase | +10,000 | $1.62 | $16,200 |
| Sep 11, 2023 | Mirum Pharmaceuticals Inc. | Open-market purchase | +10,000 | $29.65 | $296,500 |
| Aug 21, 2023 | Cerus Corporation | Open-market purchase | +10,000 | $1.72 | $17,200 |
| Jun 7, 2023 | Cerus Corporation | Grant or award | +40,000 | $5.00 | $200,000 |
| May 31, 2023 | CalciMedica Inc. | Open-market purchase | +100 | $4.09 | $409 |
| May 31, 2023 | CalciMedica Inc. | Open-market purchase | +150 | $4.20 | $630 |
| May 30, 2023 | CalciMedica Inc. | Open-market purchase | +5 | $3.25 | $16 |
| May 23, 2023 | CalciMedica Inc. | Open-market purchase | +500 | $3.27 | $1,635 |
| May 23, 2023 | Cerus Corporation | Open-market purchase | +5,000 | $2.00 | $10,000 |
| May 19, 2023 | CalciMedica Inc. | Open-market purchase | +199 | $2.65 | $527 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.